Neuroprotective actions of selective estrogen receptor modulators

Psychoneuroendocrinology

Volumn 34, Issue SUPPL. 1, 2009, Pages

  DonCarlos, Lydia L ^a   Azcoitia, Iñigo ^b   Garcia Segura, Luis M ^c  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c INSTITUTO CAJAL   (Spain)

Author keywords

Estrogen receptors; Gliosis; Glycogen synthase kinase 3; Growth factors; Selective estrogen receptor modulators

Indexed keywords

ARZOXIFENE; BAZEDOXIFENE; BRAIN DERIVED NEUROTROPHIC FACTOR; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; G PROTEIN COUPLED RECEPTOR; GENISTEIN; GLYCOGEN SYNTHASE KINASE 3; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LASOFOXIFENE; NEUROTROPHIN; OSPEMIFENE; PHOSPHATIDYLINOSITOL 3 KINASE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SEX HORMONE; SOMATOMEDIN C; STAT3 PROTEIN; TAMOXIFEN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1;

AGING; ARTICLE; BRAIN CELL; BRAIN FUNCTION; BRAIN TISSUE; DEGENERATIVE DISEASE; DEPRESSION; DISEASE COURSE; DRUG SELECTIVITY; ESTROGEN BINDING; ESTROGEN THERAPY; HUMAN; MACROGLIA; MENTAL DISEASE; MICROGLIA; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; MODELS, BIOLOGICAL; NEUROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; RECEPTORS, ESTROGEN; SELECTIVE ESTROGEN RECEPTOR MODULATORS;

EID: 71249153344     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2009.04.012     Document Type: Article

References (154)

1. Alvarez-de-la-Rosa M., Silva I., Nilsen J., Pérez M.M., Garcia-Segura L.M., Avila J., and Naftolin F. Estradiol prevents neural tau hyperphosphorylation characteristic of Alzheimer's disease. Ann. N Y Acad. Sci. 1052 (2005) 210-224
2. Arvanitis D.N., Wang H., Bagshaw R.D., Callahan J.W., and Boggs J.M. Membrane-associated estrogen receptor and caveolin-1 are present in central nervous system myelin and oligodendrocyte plasma membranes. J. Neurosci. Res. 75 (2004) 603-613
3. Azcoitia I., Sierra A., and Garcia-Segura L.M. Neuroprotective effects of estradiol in the adult rat hippocampus: interaction with insulin-like growth factor-I signalling. J. Neurosci. Res. 58 (1999) 815-822
4. Azcoitia I., Moreno A., Carrero P., Palacios S., and Garcia-Segura L.M. Neuroprotective effects of soy phytoestrogens in the rat brain. Gynecol. Endocrinol. 22 (2006) 63-69
5. Behl C. Oestrogen as a neuroprotective hormone. Nat. Rev. Neurosci. 3 (2002) 433-442
6. Belandia B., and Parker M.G. Nuclear receptors: a rendezvous for chromatin remodeling factors. Cell 114 (2003) 277-280
7. Berchtold N.C., Kesslak J.P., Pike C.J., Adlard P.A., and Cotman C.W. Estrogen and exercise interact to regulate brain-derived neurotrophic factor mRNA and protein expression in the hippocampus. Eur. J. Neurosci. 14 (2001) 1992-2002
8. Bhat R.V., Shanley J., Correll M.P., Fieles W.E., Keith R.A., Scott C.W., and Lee C.M. Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3beta in cellular and animal models of neuronal degeneration. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 11074-11079
9. Bhat R.V., Budd Haeberlein S.L., and Avila J. Glycogen synthase kinase 3: a drug target for CNS therapies. J. Neurochem. 89 (2004) 1313-1317
10. Blurton-Jones M., and Tuszynski M.H. Reactive astrocytes express estrogen receptors in the injured primate brain. J. Comp. Neurol. 433 (2001) 115-123
11. Brann D.W., Dhandapani K., Wakade C., Mahesh V.B., and Khan M.M. Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications. Steroids 72 (2007) 381-405
12. Brinton R.D. Selective estrogen receptor modulators (SERM) for the brain: recent advances and remaining challenges for developing a NeuroSERM. Drug Dev. Res. 56 (2002) 380-392
13. Brinton R.D. Requirements of a brain selective estrogen: advances and remaining challenges for developing a NeuroSERM. J. Alzheimers Dis. 6 Suppl. (2004) S27-S35
14. Brinton R.D. The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications. Trends Neurosci. 31 (2008) 529-537
15. Bryant D.N., Bosch M.A., Ronnekleiv O.K., and Dorsa D.M. 17-Beta estradiol rapidly enhances extracellular signal-regulated kinase 2 phosphorylation in the rat brain. Neuroscience 133 (2005) 343-352
16. Callier S., Morissette M., Grandbois M., Pelaprat D., and Di Paolo T. Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice. Synapse 41 (2001) 131-138
17. Cardona-Gomez G.P., Mendez P., DonCarlos L.L., Azcoitia I., and Garcia-Segura L.M. Interactions of estrogens and insulin-like growth factor-I in the brain: implications for neuroprotection. Brain Res. Rev. 37 (2001) 320-334
18. Cardona-Gomez G.P., Mendez P., and Garcia-Segura L.M. Synergistic interaction of estradiol and insulin-like growth factor-I in the activation of PI3K/Akt signaling in the adult rat hypothalamus. Mol. Brain Res. 107 (2002) 80-88
19. Cardona-Gomez P., Perez M., Avila J., Garcia-Segura L.M., and Wandosell F. Estradiol inhibits GSK3 and regulates interaction of estrogen receptors, GSK3, and beta-catenin in the hippocampus. Mol. Cell. Neurosci. 25 (2004) 363-373
20. Carroll J.C., and Pike C.J. Selective estrogen receptor modulators differentially regulate Alzheimer-like changes in female 3xTg-AD mice. Endocrinology 149 (2008) 2607-2611
21. Carswell H.V., Macrae I.M., Gallagher L., Harrop E., and Horsburgh K.J. Neuroprotection by a selective estrogen receptor beta agonist in a mouse model of global ischemia. Am. J. Physiol. Heart Circ. Physiol. 287 (2004) H1501-H1504
22. Ciana P., Ghisletti S., Mussi P., Eberini I., Vegeto E., and Maggi A. Estrogen receptor alpha, a molecular switch converting transforming growth factor-alpha-mediated proliferation into differentiation in neuroblastoma cells. J. Biol. Chem. 278 (2003) 31737-31744
23. Ciriza I., Carrero P., Azcoitia I., Lundeen S.G., and Garcia-Segura L.M. Selective estrogen receptor modulators protect hippocampal neurons from kainic acid excitotoxicity: differences with the effect of estradiol. J. Neurobiol. 61 (2004) 209-221
24. Ciriza I., Carrero P., Frye C.A., and Garcia-Segura L.M. Reduced metabolites mediate neuroprotective effects of progesterone in the adult rat hippocampus. The synthetic progestin medroxyprogesterone acetate (Provera) is not neuroprotective. J. Neurobiol. 66 (2006) 916-928
25. Cordey M., and Pike C.J. Neuroprotective properties of selective estrogen receptor agonists in cultured neurons. Brain Res. 1045 (2005) 217-223
26. D'Astous M., Mendez P., Morissette M., Garcia-Segura L.M., and Di Paolo T. Implication of the phosphatidylinositol-3 kinase/protein kinase B signaling pathway in the neuroprotective effect of estradiol in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice. Mol. Pharmacol. 69 (2006) 1492-1498
27. Dhandapani K.M., and Brann D.W. Protective effects of estrogen and selective estrogen receptor modulators in the brain. Biol. Reprod. 67 (2002) 1379-1385
28. Dhandapani K., and Brann D. Neuroprotective effects of estrogen and tamoxifen in vitro: a facilitative role for glia?. Endocrine 21 (2003) 59-66
29. Dhandapani K.M., Wade F.M., Mahesh V.B., and Brann D.W. Astrocyte-derived transforming growth factor-β mediates the neuroprotective effects of 17 β-estradiol: involvement of nonclassical genomic signaling pathways. Endocrinology 146 (2005) 2749-2759
30. Dodel R.C., Du Y., Bales K.R., Gao F., and Paul S.M. Sodium salicylate and 17beta-estradiol attenuate nuclear transcription factor NF-kappaB translocation in cultured rat astroglial cultures following exposure to amyloid A beta (1-40) and lipopolysaccharides. J. Neurochem. 73 (1999) 1453-1460
31. Drew P.D., and Chavis J.A. Female sex steroids: effects upon microglial cell activation. J. Neuroimmunol. 111 (2000) 77-85
32. Dubal D.B., Shughrue P.J., Wilson M.E., Merchenthaler I., and Wise P.M. Estradiol modulates bcl-2 in cerebral ischemia: a potential role for estrogen receptors. J. Neurosci. 19 (1999) 6385-6393
33. Dubal D.B., Rau S.W., Shughrue P.J., Zhu H., Yu J., Cashion A.B., Suzuki S., Gerhold L.M., Bottner M.B., Dubal S.B., Merchanthaler I., Kindy M.S., and Wise P.M. Differential modulation of estrogen receptors (ERs) in ischemic brain injury: a role for ERalpha in estradiol-mediated protection against delayed cell death. Endocrinology 147 (2006) 3076-3084
34. Dykens J.A., Simpkins J.W., Wang J., and Gordon K. Polycyclic phenols, estrogens and neuroprotection: a proposed mitochondrial mechanism. Exp. Gerontol. 38 (2003) 101-107
35. Enguita M., DeGregorio-Rocasolano N., Abad A., and Trullas R. Glycogen synthase kinase 3 activity mediates neuronal pentraxin 1 expression and cell death induced by potassium deprivation in cerebellar granule cells. Mol. Pharmacol. 67 (2005) 1237-1246
36. Espeland M.A., Rapp S.R., Shumaker S.A., Brunner R., Manson J.E., Sherwin B.B., Hsia J., Margolis K.L., Hoganm P.E., Wallace R., Dailey M., Freeman R., Hays J., and Women's Health Initiative Memory Study. Conjugated equine estrogens and global cognitive function in postmenopausal women: women's health initiative memory study. JAMA 291 (2004) 2959-2968
37. Funakoshi T., Yanai A., Shinoda K., Kawano M.M., and Mizukami Y. G protein-coupled receptor 30 is an estrogen receptor in the plasma membrane. Biochem. Biophys. Res. Commun. 346 (2006) 904-910
38. Gao Q., Mezei G., Nie Y., Rao Y., Choi C.S., Bechmann I., Leranth C., Toran-Allerand D., Priest C.A., Roberts J.L., Gao X.B., Mobbs C., Shulman G.I., Diano S., and Horvath T.L. Anorectic estrogen mimics leptin's effect on the rewiring of melanocortin cells and Stat3 signaling in obese animals. Nat. Med. 13 (2007) 89-94
39. Garcia-Ovejero D., Veiga S., Garcia-Segura L.M., and DonCarlos L.L. Glial expression of estrogen and androgen receptors after rat brain injury. J. Comp. Neurol. 450 (2002) 256-271
40. Garcia-Ovejero D., Azcoitia I., DonCarlos L.L., Melcangi R.C., and Garcia-Segura L.M. Glia-neuron crosstalk in the neuroprotective mechanisms of sex steroid hormones. Brain Res. Rev. 48 (2005) 273-286
41. Garcia-Segura L.M. Aromatase in the brain: not just for reproduction anymore. J. Neuroendocrinol. 20 (2008) 705-712
42. Garcia-Segura L.M., and Melcangi R.C. Steroids and glial cell function. Glia 54 (2006) 485-498
43. Garcia-Segura L.M., Azcoitia I., and DonCarlos L.L. Neuroprotection by estradiol. Prog. Neurobiol. 63 (2001) 29-60
44. Garcia-Segura L.M., Sanz A., and Mendez P. Cross-talk between IGF-I and estradiol in the brain: focus on neuroprotection. Neuroendocrinology 84 (2006) 275-279
45. Goodenough S., Schleusner D., Pietrzik C., Skutella T., and Behl C. Glycogen synthase kinase 3beta links neuroprotection by 17beta-estradiol to key Alzheimer processes. Neuroscience 132 (2005) 581-589
46. Gorosito S.V., Lorenzo A.G., and Cambiasso M.J. Estrogen receptor alpha is expressed on the cell-surface of embryonic hypothalamic neurons. Neuroscience 154 (2008) 1173-1177
47. Hammes S.R., and Levin E.R. Extra-nuclear steroid receptors: nature and actions. Endocr. Rev. 28 (2007) 726-741
48. Hart S.A., Snyder M.A., Smejkalova T., and Woolley C.S. Estrogen mobilizes a subset of estrogen receptor-alpha-immunoreactive vesicles in inhibitory presynaptic boutons in hippocampal CA1. J. Neurosci. 27 (2007) 2102-2111
49. Henderson V.W. Cognitive changes after menopause: influence of estrogen. Clin. Obstet. Gynecol. 51 (2008) 618-626
50. Henderson V.W., Paganini-Hill A., Miller B.L., Elble R.J., Reyes P.F., Shoupe D., McCleary C.A., Klein R.A., Hake A.M., and Farlow M.R. Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology 54 (2000) 295-301
51. Hewitt S.C., Deroo B.J., and Korach K.S. Signal transduction. A new mediator for an old hormone?. Science 307 (2005) 1572-1573
52. Hirahara Y., Matsuda K., Gao W., Arvanitis D.N., Kawata M., and Boggs J.M. The localization and non-genomic function of the membrane-associated estrogen receptor in oligodendrocytes. Glia 57 (2009) 153-165
53. Hsieh Y.C., Yu H.P., Suzuki T., Choudhry M.A., Schwacha M.G., Bland K.I., and Chaudry I.H. Upregulation of mitochondrial respiratory complex IV by estrogen receptor-beta is critical for inhibiting mitochondrial apoptotic signaling and restoring cardiac functions following trauma-hemorrhage. J. Mol. Cell. Cardiol. 41 (2006) 511-521
54. Jover-Mengual T., Zukin R.S., and Etgen A.M. MAPK signaling is critical to estradiol protection of CA1 neurons in global ischemia. Endocrinology 148 (2007) 1131-1143
55. Jung M.E., Wilson A.M., and Simpkins J.W. A nonfeminizing estrogen analog protects against ethanol withdrawal toxicity in immortalized hippocampal cells. J. Pharmacol. Exp. Ther. 319 (2006) 543-550
56. Kelly M.J., and Rønnekleiv O.K. Membrane-initiated estrogen signaling in hypothalamic neurons. Mol. Cell. Endocrinol. 290 (2008) 14-23
57. Kelly M.J., Ronnekleiv O.K., Ibrahim N., Lagrange A.H., and Wagner E.J. Estrogen modulation of K(+) channel activity in hypothalamic neurons involved in the control of the reproductive axis. Steroids 67 (2002) 447-456
58. Kelly M.J., Qiu J., and Ronnekleiv O.K. Estrogen signaling in the hypothalamus. Vitam. Horm. 71 (2005) 123-145
59. Kimelberg H.K., Jin Y., Charniga C., and Feustel P.J. Neuroprotective activity of tamoxifen in permanent focal ischemia. J. Neurosurg. 99 (2003) 138-142
60. Klinge C.M. Estrogen receptor interaction with co-activators and co-repressors. Steroids 65 (2000) 227-251
61. Kokiko O.N., Murashov A.K., and Hoane M.R. Administration of raloxifene reduces sensorimotor and working memory deficits following traumatic brain injury. Behav. Brain Res. 170 (2006) 233-240
62. Krug R., Born J., and Rasch B. A 3-day estrogen treatment improves prefrontal cortex-dependent cognitive function in postmenopausal women. Psychoneuroendocrinology 31 (2006) 965-975
63. LeBlanc E.S., Janowsky J., Chan B.K., and Nelson H.D. Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA 285 (2001) 1489-1499
64. Lei D.L., Long J.M., Hengemihle J., O'Neill J., Manaye K.F., Ingram D.K., and Mouton P.R. Effects of estrogen and raloxifene on neuroglia number and morphology in the hippocampus of aged female mice. Neuroscience 121 (2003) 659-666
65. Levin E.R. Integration of the extranuclear and nuclear actions of estrogen. Mol. Endocrinol. 19 (2005) 1951-1959
66. Li X., Schwartz P.E., and Rissman E.F. Distribution of estrogen receptor-beta-like immunoreactivity in rat forebrain. Neuroendocrinology 66 (1997) 63-67
67. Lord C., Buss C., Lupien S.J., and Pruessner J.C. Hippocampal volumes are larger in postmenopausal women using estrogen therapy compared to past users, never users and men: a possible window of opportunity effect. Neurobiol. Aging 29 (2008) 95-101
68. Luoma J.I., Boulware M.I., and Mermelstein P.G. Caveolin proteins and estrogen signaling in the brain. Mol. Cell. Endocrinol. 290 (2008) 8-13
69. Maki P.M. Hormone therapy and cognitive function: is there a critical period for benefit?. Neuroscience 138 (2006) 1027-1030
70. Maki P.M., Gast M.J., Vieweg A.J., Burriss S.W., and Yaffe K. Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial. Neurology 69 (2007) 1322-1330
71. Marin R., Ramírez C., Morales A., González M., Alonso R., and Díaz M. Modulation of Abeta-induced neurotoxicity by estrogen receptor alpha and other associated proteins in lipid rafts. Steroids 73 (2008) 992-996
72. Marin R., Díaz M., Alonso R., Sanz A., Arévalo M.A., and Garcia-Segura L.M. Role of estrogen receptor alpha in membrane-initiated signaling in neural cells: interaction with IGF-1 receptor. J. Steroid Biochem. Mol. Biol. 114 (2009) 2-7
73. McKenna N.P., and O'Malley B.O. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108 (2002) 465-474
74. Mehta S.H., Dhandapani K.M., De Sevilla L.M., Webb R.C., Mahesh V.B., and Brann D.W. Tamoxifen, a selective estrogen receptor modulator, reduces ischemic damage caused by middle cerebral artery occlusion in the ovariectomized female rat. Neuroendocrinology 77 (2003) 44-50
75. Mendez P., Azcoitia I., and Garcia-Segura L.M. Estrogen receptor alpha forms estrogen-dependent multimolecular complexes with insulin-like growth factor receptor and phosphatidylinositol 3-kinase in the adult rat brain. Mol. Brain Res. 112 (2003) 170-176
76. Mendez P., Wandosell F., and Garcia-Segura L.M. Cross-talk between estrogen receptors and insulin-like growth factor-I receptor in the brain: cellular and molecular mechanisms. Front. Neuroendocrinol. 27 (2006) 391-403
77. Merchenthaler I., Dellovade T.L., and Shughrue P.J. Neuroprotection by estrogen in animal models of global and focal ischemia. Ann. N Y Acad. Sci. 1007 (2003) 89-100
78. Micevych P.E., and Mermelstein P.G. Membrane estrogen receptors acting through metabotropic glutamate receptors: an emerging mechanism of estrogen action in brain. Mol. Neurobiol. 38 (2008) 66-77
79. Mickley K.R., and Dluzen D.E. Dose-response effects of estrogen and tamoxifen upon methamphetamine-induced behavioral responses and neurotoxicity of the nigrostriatal dopaminergic system in female mice. Neuroendocrinology 79 (2004) 305-316
80. Miller N.R., Jover T., Cohen H.W., Zukin R.S., and Etgen A.M. Estrogen can act via estrogen receptor alpha and beta to protect hippocampal neurons against global ischemia-induced cell death. Endocrinology 146 (2005) 3070-3079
81. Milner T.A., McEwen B.S., Hayashi S., Li C.J., Reagan L.P., and Alves S.E. Ultrastructural evidence that hippocampal alpha estrogen receptors are located at extranuclear sites. J. Comp. Neurol. 429 (2001) 355-371
82. Milner T.A., Ayoola K., Drake C.T., Herrick S.P., Tabori N.E., McEwen B.S., Warrier S., and Alves S.E. Ultrastructural localization of estrogen receptor beta immunoreactivity in the rat hippocampal formation. J. Comp. Neurol. 491 (2005) 81-95
83. Morissette M., Al Sweidi S., Callier S., and Di Paolo T. Estrogen and SERM neuroprotection in animal models of Parkinson's disease. Mol. Cell. Endocrinol. 290 (2008) 60-69
84. Morissette M., Le Saux M., D'Astous M., Jourdain S., Al Sweidi S., Morin N., Estrada-Camarena E., Mendez P., Garcia-Segura L.M., and Di Paolo T. Contribution of estrogen receptors alpha and beta to the effects of estradiol in the brain. J. Steroid Biochem. Mol. Biol. 108 (2008) 327-338
85. Nilsen J., and Brinton R.D. Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate. Endocrinology 143 (2002) 205-212
86. Nilsen J., and Brinton R.D. Mechanism of estrogen-mediated neuroprotection: regulation of mitochondrial calcium and Bcl-2 expression. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 2842-2847
87. Nilsen J., Morales A., and Brinton R.D. Medroxyprogesterone acetate exacerbates glutamate excitotoxicity. Gynecol. Endocrinol. 22 (2006) 355-361
88. Nilsson S., Makela S., Treuter E., Tujague M., Thomsen J., Andersson G., Enmark E., Pettersson K., Warner M., and Gustafsson J.A. Mechanisms of estrogen action. Physiol. Rev. 81 (2001) 1535-1565
89. Pawlak J., Karolczak M., Krust A., Chambon P., and Beyer C. Estrogen receptor-alpha is associated with the plasma membrane of astrocytes and coupled to the MAP/Src-kinase pathway. Glia 50 (2005) 270-275
90. Pedram A., Razandi M., and Levin E.R. Nature of functional estrogen receptors at the plasma membrane. Mol. Endocrinol. 20 (2006) 1996-2009
91. Perez E., Liu R., Yang S.H., Cai Z.Y., Covey D.F., and Simpkins J.W. Neuroprotective effects of an estratriene analog are estrogen receptor independent in vitro and in vivo. Brain Res. 1038 (2005) 216-222
92. Picazo O., Azcoitia I., and Garcia-Segura L.M. Neuroprotective and neurotoxic effects of estrogens. Brain Res. 990 (2003) 20-27
93. Quesada A., and Micevych P.E. Estrogen interacts with the IGF-1 system to protect nigrostriatal dopamine and maintain motoric behavior after 6-hydroxdopamine lesions. J. Neurosci. Res. 75 (2004) 107-116
94. Ragonese P., D'Amelio M., and Savettieri G. Implications for estrogens in Parkinson's disease: an epidemiological approach. Ann. N Y Acad. Sci. 1089 (2006) 373-382
95. Resnick S.M., and Maki P.M. Effects of hormone replacement therapy on cognitive and brain aging. Ann. N Y Acad. Sci. 949 (2001) 203-214
96. Resnick S.M., Maki P.M., Rapp S.R., Espeland M.A., Brunner R., Coker L.H., Granek I.A., Hogan P., Ockene J.K., and Shumaker S.A. Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J. Clin. Endocrinol. Metab. 91 (2006) 1802-1810
97. Revankar C.M., Cimino D.F., Sklar L.A., Arterburnm J.B., and Prossnitz E.R. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307 (2005) 1625-1630
98. Riggs B.L., and Hartmann L.C. Selective estrogen-receptor modulators-mechanisms of action and application to clinical practice. N. Engl. J. Med. 348 (2003) 618-629
99. Rossberg M.I., Murphy S.J., Traystman R.J., and Hurn P.D. LY353381.HCl, a selective estrogen receptor modulator, and experimental stroke. Stroke 31 (2000) 3041-3046
100. Saunders-Pullman R. Estrogens and Parkinson disease: neuroprotective, symptomatic, neither, or both?. Endocrine 21 (2003) 81-87
101. Scharfman H.E., and Maclusky N.J. Similarities between actions of estrogen and BDNF in the hippocampus: coincidence or clue?. Trends Neurosci. 28 (2005) 79-85
102. Scharfman H.E., and MacLusky N.J. Estrogen and brain-derived neurotrophic factor (BDNF) in hippocampus: complexity of steroid hormone-growth factor interactions in the adult CNS. Front. Neuroendocrinol. 27 (2006) 413-415
103. Schwend T., and Gustafsson J.A. False positives in MALDI-TOF detection of ERbeta in mitochondria. Biochem. Biophys. Res. Commun. 343 (2006) 707-711
104. Shaywitz B.A., and Shaywitz S.E. Estrogen and Alzheimer disease: plausible theory, negative clinical trial. JAMA 283 (2000) 1055-1056
105. Shelly W., Draper M.W., Krishnan V., Wong M., and Jaffe R.B. Selective estrogen receptor modulators: an update on recent clinical findings. Obstet. Gynecol. Surv. 63 (2008) 163-181
106. Sherwin B.B. Estrogen and cognitive aging in women. Neuroscience 138 (2006) 1021-1026
107. Sherwin B.B. The critical period hypothesis: can it explain discrepancies in the oestrogen-cognition literature?. J. Neuroendocrinol. 19 (2007) 77-81
108. Shughrue P.J., Lane M.V., and Merchenthaler I. Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J. Comp. Neurol. 388 (1997) 507-525
109. Shughrue P., Scrimo P., Lane M., Askew R., and Merchenthaler I. The distribution of estrogen receptor-β mRNA in forebrain regions of the estrogen receptor-α knockout mouse. Endocrinology 138 (1997) 5649-5652
110. Shughrue P.J., Scrimo P.J., and Merchenthaler I. Evidence for the colocalization of estrogen receptor-β mRNA and estrogen receptor-α immunoreactivity in neurons of the rat forebrain. Endocrinology 139 (1998) 5267-5270
111. Shumaker S.A., Legault C., Rapp S.R., Thal L., Wallace R.B., Ockene J.K., Hendrix S.L., Jones B.N., Assaf A.R., Jackson R.D., Kotchen J.M., Wassertheil-Smoller S., Wactawski-Wende J., and WHIMS Investigators. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289 (2003) 2651-2662
112. Shumaker S.A., Legault C., Kuller L., Rapp S.R., Thal L., Lane D.S., Fillit H., Stefanick M.L., Hendrix S.L., Lewis C.E., Masaki K., Coker L.H., and Women's Health Initiative Memory Study. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 291 (2004) 2947-2958
113. Simpkins J.W., and Singh M. More than a decade of estrogen neuroprotection. Alzheimers Dement. 4 Suppl. 1 (2008) S131-S136
114. Simpkins J.W., Yang S.H., Liu R., Perez E., Cai Z.Y., Covey D.F., and Green P.S. Estrogen-like compounds for ischemic neuroprotection. Stroke 35 Suppl. 1 (2004) 2648-2651
115. Simpkins J.W., Wen Y., Perez E., Yang S., and Wang X. Role of nonfeminizing estrogens in brain protection from cerebral ischemia: an animal model of Alzheimer's disease neuropathology. Ann. N Y Acad. Sci. 1052 (2005) 233-242
116. Simpkins J.W., Wang J., Wang X., Perez E., Prokai L., and Dykens J.A. Mitochondria play a central role in estrogen-induced neuroprotection. Curr. Drug Targets CNS Neurol. Disord. 4 (2005) 69-83
117. Simpkins J.W., Yang S.H., Sarkar S.N., and Pearce V. Estrogen actions on mitochondria-physiological and pathological implications. Mol. Cell. Endocrinol. 290 (2008) 51-59
118. Singh M., Setalo G., Guan X., Frail D.E., and Toran-Allerand C.D. Estrogen-induced activation of the mitogen-activated protein kinase cascade in the cerebral cortex of estrogen receptor-alpha knock-out mice. J. Neurosci. 20 (2000) 1694-1700
119. Smith C.L., and O'Malley B.W. Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr. Rev. 25 (2004) 45-71
120. Sohrabji F., and Lewis D.K. Estrogen-BDNF interactions: implications for neurodegenerative diseases. Front. Neuroendocrinol. 27 (2006) 144-404
121. Sohrabji F., Miranda R.C., and Toran-Allerand C.D. Identification of a putative estrogen response element in the gene encoding brain-derived neurotrophic factor. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 11110-11114
122. Sortino M.A., Chisari M., Merlo S., Vancheri C., Caruso M., Nicoletti F., Canonico P.L., and Copani A. Glia mediates the neuroprotective action of estradiol on beta-amyloid-induced neuronal death. Endocrinology 145 (2004) 5080-5086
123. Spencer J.L., Waters E.M., Romeo R.D., Wood G.E., Milner T.A., and McEwen B.S. Uncovering the mechanisms of estrogen effects on hippocampal function. Front. Neuroendocrinol. 29 (2008) 219-237
124. Suuronen T., Nuutinen T., Huuskonen J., Ojala J., Thornell A., and Salminen A. Anti-inflammatory effect of selective estrogen receptor modulators (SERMs) in microglial cells. Inflamm. Res. 54 (2005) 194-203
125. Suzuki S., Brown C.M., and Wise P.M. Mechanisms of neuroprotection by estrogen. Endocrine 29 (2006) 209-215
126. Suzuki S., Brown C.M., De la Cruz C.D., Yangm E., Bridwellm D.A., and Wise P.M. Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 6013-6018
127. Suzuki S., Gerhold L.M., Böttner M., Rau S.W., De la Cruz C., Yang E., Zhu H., Yu J., Cashion A.B., Kindy M.S., Merchenthaler I., Gage F.H., and Wise P.M. Estradiol enhances neurogenesis following ischemic stroke through estrogen receptors alpha and beta. J. Comp. Neurol. 500 (2007) 1064-1075
128. Tapia-Gonzalez S., Carrero P., Pernia O., Garcia-Segura L.M., and Diz-Chaves Y. Selective oestrogen receptor (ER) modulators reduce microglia reactivity in vivo after peripheral inflammation: potential role of microglial ERs. J. Endocrinol. 198 (2008) 219-230
129. Toran-Allerand C.D. Minireview: a plethora of estrogen receptors in the brain: where will it end?. Endocrinology 145 (2004) 1069-1074
130. Toran-Allerand C.D., Tinnikov A.A., Singh R.J., and Nethrapalli I.S. 17α-estradiol: a brain-active estrogen?. Endocrinology 146 (2005) 3843-3850
131. Vasudevan N., and Pfaff D.W. Non-genomic actions of estrogens and their interaction with genomic actions in the brain. Front. Neuroendocrinol. 29 (2008) 238-257
132. Vegeto E., Belcredito S., Ghisletti S., Meda C., Etteri S., and Maggi A. The endogenous estrogen status regulates microglia reactivity in animal models of neuroinflammation. Endocrinology 147 (2006) 2263-2272
133. Vegeto E., Benedusi V., and Maggi A. Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases. Front. Neuroendocrinol. 29 (2008) 507-519
134. Viscoli C.M., Brass L.M., Kernan W.N., Sarrel P.M., Suissa S., and Horwitz R.I. A clinical trial of estrogen-replacement therapy after ischemic stroke. N. Engl. J. Med. 345 (2001) 1243-1249
135. 2 toxicity in human neuroblastoma SK-N-SH cells. Mol. Pharmacol. 70 (2006) 395-404
136. Wassertheil-Smoller S., Hendrix S.L., Limacher M., Heiss G., Kooperberg C., Baird A., Kotchen T., Curb J.D., Black H., Rossouw J.E., Aragaki A., Safford M., Stein E., Laowattana S., and Mysiw W.J. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA 289 (2003) 2673-2684
137. Watters J.J., Campbell J.S., Cunningham M.J., Krebs E.G., and Dorsa D.M. Rapid membrane effects of steroids in neuroblastoma cells: effects of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription. Endocrinology 138 (1997) 4030-4033
138. Webb P., Lopez G.N., Uht R.M., and Kushner P.J. Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol. Endocrinol. 9 (1995) 443-456
139. Wise P.M. Estradiol exerts neuroprotective actions against ischemic brain injury: insights derived from animal models. Endocrine 21 (2003) 11-15
140. Wise P.M. Estrogens: protective or risk factors in brain function?. Prog. Neurobiol. 69 (2003) 181-191
141. Wise P.M., Dubal D.B., Rau S.W., Brown C.M., and Suzuki S. Are estrogens protective or risk factors in brain injury and neurodegeneration? Reevaluation after the Women's health initiative. Endocr. Rev. 26 (2005) 308-312
142. Woolley C.S. Acute effects of estrogen on neuronal physiology. Annu. Rev. Pharmacol. Toxicol. 47 (2007) 657-680
143. Xu H., Qin S., Carrasco G.A., Dai Y., Filardo E.J., Prossnitz E.R., Battaglia G., DonCarlos L.L., and Muma N.A. Extra-nuclear estrogen receptor GPR30 regulates serotonin function in rat hypothalamus. Neuroscience 158 (2009) 1599-1607
144. Yaffe K. Hormone therapy and the brain: deja vu all over again?. JAMA 289 (2003) 2717-2719
145. Yaffe K., Sawaya G., Lieberburg I., and Grady D. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 279 (1998) 688-695
146. Yaffe K., Barnes D., Lindquist K., Cauley J., Simonsick E.M., Penninx B., Satterfield S., Harris T., Cummings S.R., and Health ABC Investigators. Endogenous sex hormone levels and risk of cognitive decline in an older biracial cohort. Neurobiol. Aging 28 (2007) 171-178
147. Yang S.H., Liu R., Perez E.J., Wen Y., Stevens S.M., Valencia T., Brun-Zinkernagel A.M., Prokai L., Will Y., Dykens J., Koulen P., and Simpkins J.W. Mitochondrial localization of estrogen receptor beta. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 4130-4135
148. Yang S.H., Prokai L., and Simpkins J.W. Correspondence regarding Schwend and Gustafsson, "False positives in MALDI-TOF detection of ERbeta in mitochondria". Biochem. Biophys. Res. Commun. 345 (2006) 917-918
149. Zandi P.P., Carlson M.C., Plassman B.L., Welsh-Bohmer K.A., Mayer L.S., Steffens D.C., Breitner J.C., and Cache County Memory Study Investigators. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 288 (2002) 2123-2129
150. Zhao L., and Brinton R.D. Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease. BMC Neurosci. 7 (2006) 24
151. Zhao L., and Brinton R.D. Estrogen receptor alpha and beta differentially regulate intracellular Ca(2+) dynamics leading to ERK phosphorylation and estrogen neuroprotection in hippocampal neurons. Brain Res. 1172 (2007) 48-59
152. Zhao L., Wu T.W., and Brinton R.D. Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons. Brain Res. 1010 (2004) 22-34
153. Zhao L., O'Neill K., and Brinton R.D. Selective estrogen receptor modulators (SERMs) for the brain: current status and remaining challenges for developing NeuroSERMs. Brain Res. Rev. 49 (2005) 472-493
154. Zhao L., O'Neill K., and Brinton R.D. Estrogenic agonist activity of ICI, 182, 780 (Faslodex) in hippocampal neurons: implications for basic science understanding of estrogen signaling and development of estrogen modulators with a dual therapeutic profile. J. Pharmacol. Exp. Ther. 319 (2006) 1124-1132